• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化因子VIII(FVIIIa)在凝血起始阶段FVIIa/组织因子依赖性FXa生成中的潜在作用。

Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.

作者信息

Furukawa Shoko, Nogami Keiji, Ogiwara Kenichi, Shima Midori

机构信息

Department of Pediatrics, Nara Medical University, 840 Shijo-cho, 634-8522, Kashihara, Nara, Japan.

出版信息

Int J Hematol. 2019 Apr;109(4):390-401. doi: 10.1007/s12185-019-02611-3. Epub 2019 Feb 13.

DOI:10.1007/s12185-019-02611-3
PMID:30756344
Abstract

Factor VIIa/tissue factor (FVIIa/TF) initiates blood coagulation by promoting FXa generation (extrinsic-Xa). Subsequent generation of intrinsic FXa (intrinsic-Xa) amplifies thrombin formation. Previous studies suggested that FVIIa/TF activates FVIII rapidly in immediate coagulation reactions, and FVIIa/TF/FXa activates FVIII prior to thrombin-dependent feedback. We investigated FVIII/FVIIa/TF/FXa relationships in early coagulation mechanisms. Total FXa generated by FVIIa/TF and FVIIa/TF-activated FVIII (FVIIIa) was 22.6 ± 1.7 nM (1 min); total FXa with FVIIa-inhibitor was 3.4 ± 0.7 nM, whereas FXa generated by FVIIa/TF or FVIII/TF was 10.4 ± 1.1 or 0.74 ± 0.14 nM, respectively. Little Xa was generated by FVIII alone, suggesting that intrinsic-Xa mechanisms were mediated by FVIIIa and FVIII/TF in the initiation phase. Intrinsic-Xa was delayed somewhat by von Willebrand factor (VWF). FVIII activation by FXa with FVIIa/TF was comparable to activation with Glu-Gly-Arg-inactivated-FVIIa/TF. TF counteracted the inhibitory effects of VWF on FXa-induced FVIII activation mediated by Arg cleavage. The FVIII-C2 domain bound to cytoplasmic domain-deleted TF (TF), and VWF blocked this binding by > 80%, indicating an overlap between VWF- and TF-binding site(s) on C2. Overall, these data suggest that FVIII-associated intrinsic-Xa, governed by both FVIIa/TF-induced and FXa-induced FVIII activation mediated by FVIII-TF interactions, together with FVIIa-dependent extrinsic-Xa mechanisms, may be central to the initiation phase of coagulation.

摘要

凝血因子VIIa/组织因子(FVIIa/TF)通过促进因子Xa(FXa)生成(外源性Xa)启动血液凝固。随后内源性FXa(内源性Xa)的生成会放大凝血酶的形成。先前的研究表明,在即时凝血反应中FVIIa/TF能迅速激活FVIII,并且在凝血酶依赖性反馈之前FVIIa/TF/FXa就能激活FVIII。我们研究了早期凝血机制中FVIII/FVIIa/TF/FXa之间的关系。FVIIa/TF和FVIIa/TF激活的FVIII(FVIIIa)产生的总FXa为22.6±1.7 nM(1分钟);使用FVIIa抑制剂时总FXa为3.4±0.7 nM,而FVIIa/TF或FVIII/TF产生的FXa分别为10.4±1.1 nM或0.74±0.14 nM。单独的FVIII产生的Xa很少,这表明在内源性Xa机制在起始阶段是由FVIIIa和FVIII/TF介导的。内源性Xa会因血管性血友病因子(VWF)而有所延迟。FXa与FVIIa/TF一起对FVIII的激活与用Glu-Gly-Arg失活的FVIIa/TF激活相当。TF抵消了VWF对由精氨酸裂解介导的FXa诱导的FVIII激活的抑制作用。FVIII的C2结构域与缺失细胞质结构域的TF(TF)结合,并且VWF使这种结合减少了>80%,表明C2上VWF结合位点和TF结合位点存在重叠。总体而言,这些数据表明,由FVIIa/TF诱导和由FVIII-TF相互作用介导的FXa诱导的FVIII激活共同控制的FVIII相关内源性Xa,与FVIIa依赖性外源性Xa机制一起,可能是凝血起始阶段的核心。

相似文献

1
Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.活化因子VIII(FVIIIa)在凝血起始阶段FVIIa/组织因子依赖性FXa生成中的潜在作用。
Int J Hematol. 2019 Apr;109(4):390-401. doi: 10.1007/s12185-019-02611-3. Epub 2019 Feb 13.
2
Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.组织因子-因子VIIa-因子Xa复合物对因子VIII的选择性激活。
Blood. 2017 Oct 5;130(14):1661-1670. doi: 10.1182/blood-2017-02-767079. Epub 2017 Jul 20.
3
Mechanisms of factor VIIa-catalyzed activation of factor VIII.因子 VIIa 催化因子 VIII 激活的机制。
J Thromb Haemost. 2010 Nov;8(11):2494-503. doi: 10.1111/j.1538-7836.2010.04042.x.
4
Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.成纤维细胞在凝血因子VIIa与组织因子结合后产生血管内皮生长因子的过程涉及凝血酶和因子Xa。
Arterioscler Thromb Vasc Biol. 2000 May;20(5):1374-81. doi: 10.1161/01.atv.20.5.1374.
5
Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII.抗凝血因子 VIII 抑制剂抗体对凝血因子 VIIa/组织因子催化的凝血因子 VIII 激活和失活的影响。
Thromb Haemost. 2011 Jun;105(6):989-98. doi: 10.1160/TH10-12-0781. Epub 2011 Mar 24.
6
The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.组织因子/因子VIIa/因子Xa复合物:通过对接和定点诱变构建的模型。
Proteins. 2003 Nov 15;53(3):640-8. doi: 10.1002/prot.10445.
7
Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.组织因子抑制物:TFPI 和 TFPI 构建体对因子 VIIa 催化的因子 IX 和因子 X 的激活作用。
J Thromb Haemost. 2014 Nov;12(11):1826-37. doi: 10.1111/jth.12713. Epub 2014 Oct 12.
8
A molecular dynamics simulation study to understand the effect of cholesterol and tissue factor palmitoylation on tissue factor-factor VIIa-factor Xa ternary complex in different lipid environments.一项分子动力学模拟研究,旨在了解胆固醇和组织因子棕榈酰化对不同脂质环境中组织因子-因子 VIIa-因子 Xa 三元复合物的影响。
J Thromb Haemost. 2023 Apr;21(4):917-932. doi: 10.1016/j.jtha.2022.12.020. Epub 2022 Dec 29.
9
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.组织因子及因子X依赖的凝血因子VIIa对蛋白酶激活受体2的激活作用。
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5255-60. doi: 10.1073/pnas.97.10.5255.
10
The role of proteolytic cleavage at Arg and Arg of the A1 domain in factor VIIa/tissue factor-catalyzed reactions of B domain-deleted factor VIII.A1结构域中精氨酸残基处的蛋白水解切割在因子VIIa/组织因子催化的缺失B结构域的因子VIII反应中的作用
Biochim Biophys Acta Gen Subj. 2024 Jan;1868(1):130501. doi: 10.1016/j.bbagen.2023.130501. Epub 2023 Nov 2.

引用本文的文献

1
Liposomal factor VIII as an efficient pharmaceutical system for the treatment of hemophilia.脂质体凝血因子VIII作为治疗血友病的一种有效药物系统。
Iran J Basic Med Sci. 2024;27(6):747-754. doi: 10.22038/IJBMS.2024.74673.16214.
2
Differences in wild-type- and R338L-tenase complex formation are at the root of R338L-factor IX assay discrepancies.野生型和 R338L -tenase 复合物形成的差异是导致 R338L 因子 IX 检测差异的根源。
Blood Adv. 2023 Feb 14;7(3):458-467. doi: 10.1182/bloodadvances.2022007435.
3
A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy.

本文引用的文献

1
Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor.因子 (F)VIII/VIIa 与旁路制剂和因子 VIII 共同存在时可增强伴有抑制物的血友病 A 患者的整体止血功能。
Br J Haematol. 2018 May;181(4):528-536. doi: 10.1111/bjh.15209. Epub 2018 Apr 2.
2
Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.组织因子-因子VIIa-因子Xa复合物对因子VIII的选择性激活。
Blood. 2017 Oct 5;130(14):1661-1670. doi: 10.1182/blood-2017-02-767079. Epub 2017 Jul 20.
3
Structure-Function Relationship of the Interaction between Tissue Factor and Factor VIIa.
关于新型冠状病毒2型凝血障碍的病理生理学观点。
Hemasphere. 2020 Aug 10;4(4):e457. doi: 10.1097/HS9.0000000000000457. eCollection 2020 Aug.
组织因子与因子VIIa相互作用的结构-功能关系
Semin Thromb Hemost. 2015 Oct;41(7):682-90. doi: 10.1055/s-0035-1564044. Epub 2015 Sep 26.
4
Biology of tissue factor pathway inhibitor.组织因子途径抑制物的生物学特性。
Blood. 2014 May 8;123(19):2934-43. doi: 10.1182/blood-2013-11-512764. Epub 2014 Mar 11.
5
Activated prothrombin complex concentrate (APCC)-mediated activation of factor (F)VIII in mixtures of FVIII and APCC enhances hemostatic effectiveness.激活的凝血酶原复合物浓缩物(APCC)在 FVIII 和 APCC 的混合物中对 FVIII 的激活增强了止血效果。
J Thromb Haemost. 2013 May;11(5):902-10. doi: 10.1111/jth.12197.
6
Tissue factor pathway inhibitor: structure-function.组织因子途径抑制剂:结构-功能。
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.
7
Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII.抗凝血因子 VIII 抑制剂抗体对凝血因子 VIIa/组织因子催化的凝血因子 VIII 激活和失活的影响。
Thromb Haemost. 2011 Jun;105(6):989-98. doi: 10.1160/TH10-12-0781. Epub 2011 Mar 24.
8
Combination of FVIII and by-passing agent potentiates in vitro thrombin production in haemophilia A inhibitor plasma.FVIII 和旁路剂的联合作用可增强血友病 A 抑制剂血浆中凝血酶的体外生成。
Br J Haematol. 2010 Nov;151(4):381-6. doi: 10.1111/j.1365-2141.2010.08378.x. Epub 2010 Oct 1.
9
Mechanisms of factor VIIa-catalyzed activation of factor VIII.因子 VIIa 催化因子 VIII 激活的机制。
J Thromb Haemost. 2010 Nov;8(11):2494-503. doi: 10.1111/j.1538-7836.2010.04042.x.
10
Identification of plasmin-interactive sites in the light chain of factor VIII responsible for proteolytic cleavage at Lys36.鉴定VIII因子轻链中负责在Lys36处进行蛋白水解切割的纤溶酶相互作用位点。
J Biol Chem. 2009 Mar 13;284(11):6934-45. doi: 10.1074/jbc.M802224200. Epub 2009 Jan 6.